4 terminated. 4 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 4 |
| Phase 1 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Pt: new trials by email Literature Review of Pt trials Research Report on Pt
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration - CIC-Rearranged Sarcoma, Metastatic Ewing Sarcoma | Phase 2 / Phase 3 | Terminated | Children's Oncology Group | 2 | 2025-11-10 | 2026-10-05 |
| Immunotherapy With or Without Radiation Therapy for Metastatic Urothelial Cancer Biospecimen Collection, Bone Scan, Computed Tomography - Metastatic Urothelial Carcinoma, Platinum-Resistant Urothelial Carcinoma | Phase 2 | Terminated | National Cancer Institute (NCI) | 1 | 2022-11-22 | 2025-08-17 |
| Testing the Addition of an Anti-cancer Drug, Hu5F9-G4 (Magrolimab), to the Usual Chemotherapy Treatment (Mogamulizumab) in T-Cell (a Type of Immune Cell) Lymphoma That Has Returned After Treatment or Does Not Respond to Treatment Biospecimen Collection, Computed Tomography, Magrolimab - Mycosis Fungoides, Recurrent Mycosis Fungoides | Phase 1 / Phase 2 | Terminated | National Cancer Institute (NCI) | 8 | 2021-04-06 | 2025-10-16 |
| A Safety and Efficacy Trial of Stannsoporfin in Neonates With Hyperbilirubinemia Stannsoporfin, Placebo, PhotoTherapy (as needed) - Hyperbilirubinemia, Neonatal | Phase 2 | Terminated | InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company | 58 | 2008-08-01 | 2019-10-30 |
Carcinoma, Transitional Cell (1) · Hemolysis (1) · Hyperbilirubinemia, Neonatal (1) · Mycosis Fungoides (1) · Sarcoma, Ewing (1) · Sezary Syndrome (1) · Urinary Bladder Neoplasms (1)
National Cancer Institute (NCI) (2) · Children's Oncology Group (1) · InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company (1)
United States (4) · Poland (1) · Spain (1) · Ukraine (1)
Bhuvana A Setty (1) · Himanshu Nagar (1) · Michael S Khodadoust (1)
2009 (1), U10CA180821 (1), U10CA180886 (1), UM1CA186717 (1)